Celiprolol May Be Protective in COL3A1-positive Vascular EDS

Celiprolol May Be Protective in COL3A1-positive Vascular EDS

285532

Celiprolol May Be Protective in COL3A1-positive Vascular EDS

The therapy celiprolol may have a protective effect in COL3A1-positive patients with vascular Ehlers-Danlos syndrome (vEDS), according to results of a long-term study. The data were published in the European Journal of Vascular & Endovascular Surgery, in the article “Celiprolol Treatment in Patients with Vascular Ehlers-Danlos Syndrome.” Considered the most severe form of EDS, vEDS is marked by impaired production of the tissue’s structural protein collagen, often due to mutations in the COL3A1 gene. Patients…

You must be logged in to read/download the full post.